{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:25:29Z","timestamp":1777645529888,"version":"3.51.4"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejpb.2025.114813","type":"journal-article","created":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T14:26:25Z","timestamp":1753021585000},"page":"114813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development of an ophthalmic solution combining allogenic plasma with protective excipients for enhanced therapeutic role in the management of ocular surface diseases"],"prefix":"10.1016","volume":"214","author":[{"given":"Agn\u00e8s","family":"Roche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8086-7517","authenticated-orcid":false,"given":"Philip","family":"Chennell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Chiambaretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Fran\u00e7oise","family":"Serre-Sapin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Wasiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6937-1796","authenticated-orcid":false,"given":"Yassine","family":"Bouattour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Bailly-De-France","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Fogli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Durif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9gine","family":"Quinard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireille","family":"Jouannet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Sapin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3944-3752","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Sautou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114813_b0005","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejpb.2025.114813_b0010","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejpb.2025.114813_b0015","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","article-title":"TFOS DEWS II Pain and sensation report","volume":"15","author":"Belmonte","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejpb.2025.114813_b0020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejpb.2025.114813_b0025","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1177\/11206721221141481","article-title":"a panel of European dry eye disease experts, Management of inflammation in dry eye disease: Recommendations from a European panel of experts","volume":"33","author":"Messmer","year":"2023","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2025.114813_b0030","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.3390\/jcm11236975","article-title":"Clinical efficacy, tolerability and safety of a new multiple-action eyedrop in subjects with moderate to severe dry eye","volume":"11","author":"Roszkowska","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejpb.2025.114813_b0035","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s40123-022-00518-7","article-title":"Effects of a new formulation of multiple-action tear substitute on objective ocular surface parameters and ocular discomfort symptoms in patients with dry eye disease","volume":"11","author":"Vigo","year":"2022","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.ejpb.2025.114813_b0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajo.2004.08.040","article-title":"The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study","volume":"139","author":"Kojima","year":"2005","journal-title":"Am. J. Ophthalmol."},{"issue":"Suppl 1","key":"10.1016\/j.ejpb.2025.114813_b0045","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/ICO.0b013e31817f3a0e","article-title":"Autologous serum eye drops for the treatment of dry eye diseases","volume":"27","author":"Kojima","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2025.114813_b0050","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bjo.83.4.390","article-title":"Treatment of dry eye by autologous serum application in Sj\u00f6gren\u2019s syndrome","volume":"83","author":"Tsubota","year":"1999","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2025.114813_b0055","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0161-6420(99)90412-8","article-title":"Treatment of persistent corneal epithelial defect by autologous serum application","volume":"106","author":"Tsubota","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2025.114813_b0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fmed.2018.00033","article-title":"Reflections on dry eye syndrome treatment: therapeutic role of blood products","volume":"5","author":"Drew","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.ejpb.2025.114813_b0065","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijpharm.2016.05.045","article-title":"Platelet lysate and chondroitin sulfate loaded contact lenses to heal corneal lesions","volume":"509","author":"Sandri","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114813_b0070","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.actbio.2010.10.009","article-title":"Development of nano- and microscale chondroitin sulfate particles for controlled growth factor delivery","volume":"7","author":"Lim","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2025.114813_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.12.059","article-title":"Thermosensitive eyedrops containing platelet lysate for the treatment of corneal ulcers","volume":"426","author":"Sandri","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114813_b0080","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","article-title":"Anatomy of cornea and ocular surface","volume":"66","author":"Sridhar","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2025.114813_b0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/2230-973X.177823","article-title":"Chondroitin sulfate-chitosan nanoparticles for ocular delivery of bromfenac sodium: improved permeation, retention, and penetration","volume":"6","author":"Abdullah","year":"2016","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.ejpb.2025.114813_b0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3341\/kjo.2007.21.4.189","article-title":"Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye","volume":"21","author":"Moon","year":"2007","journal-title":"Korean J. Ophthalmol KJO"},{"key":"10.1016\/j.ejpb.2025.114813_b0095","article-title":"Dry eye treatment with topical cyclosporine 0.1% in chondroitin sulfate ophthalmic emulsion","volume":"15","author":"Matossian","year":"2021","journal-title":"Clin. Ophthalmol. Auckl. NZ"},{"key":"10.1016\/j.ejpb.2025.114813_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2023.101845","article-title":"Efficacy of artificial tears containing trehalose and hyaluronic acid for dry eye disease in women aged 42-54 versus\u226555years","author":"Mateo-Orobia","year":"2023","journal-title":"Contact Lens Anterior Eye J. Br. Contact Lens Assoc."},{"key":"10.1016\/j.ejpb.2025.114813_b0105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/pharmaceutics14010118","article-title":"Physicochemical stability of a novel tacrolimus ophthalmic formulation for the treatment of ophthalmic inflammatory diseases","volume":"14","author":"Barrieu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114813_b0110","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/02713683.2020.1849733","article-title":"Efficacy and safety of sodium hyaluronate\/chondroitin sulfate preservative-free ophthalmic solution in the treatment of dry eye: a clinical trial","volume":"46","author":"Belalc\u00e1zar-Rey","year":"2021","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejpb.2025.114813_b0115","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3390\/pharmaceutics15020578","article-title":"Evaluation of conventional and hyaluronic acid-coated thymoquinone liposomes in an in vitro model of dry eye","volume":"15","author":"Landucci","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114813_b0120","article-title":"A comparison between hyaluronic acid and other single ingredient eye drops for dry eye, a review","author":"Hynnekleiv","year":"2023","journal-title":"Acta Ophthalmol. (Copenh.)"},{"key":"10.1016\/j.ejpb.2025.114813_b0125","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/aos.15159","article-title":"Hyaluronic acid in the treatment of dry eye disease","volume":"100","author":"Hynnekleiv","year":"2022","journal-title":"Acta Ophthalmol. (Copenh.)"},{"key":"10.1016\/j.ejpb.2025.114813_b0130","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3390\/biom11101431","article-title":"Insight into the lubrication and adhesion properties of hyaluronan for ocular drug delivery","volume":"11","author":"\u010cernohl\u00e1vek","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejpb.2025.114813_b0135","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/jop.2021.0121","article-title":"Autophagy protects ocular surface against overactivated inflammation by degrading retinoic acid-induced gene-I in human conjunctival epithelial cells","volume":"38","author":"Zhou","year":"2022","journal-title":"J. Ocul. Pharmacol. Ther. Off. J. Assoc. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2025.114813_b0140","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/jop.2020.0119","article-title":"Commercially available eye drops containing trehalose protect against dry conditions via autophagy induction","volume":"37","author":"Hernandez","year":"2021","journal-title":"J. Ocul. Pharmacol. Ther. Off. J. Assoc. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2025.114813_b0145","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3390\/biom10050809","article-title":"Trehalose for ocular surface health","volume":"10","author":"Laihia","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejpb.2025.114813_b0150","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1007\/s00253-018-8814-y","article-title":"Biotechnical production of trehalose through the trehalose synthase pathway: current status and future prospects","volume":"102","author":"Cai","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejpb.2025.114813_b0155","first-page":"67","article-title":"Biotechnological production of hyaluronic acid: a mini review","author":"Sze","year":"2016","journal-title":"3 Biotech 6"},{"key":"10.1016\/j.ejpb.2025.114813_b0160","article-title":"Heterologous production of chondroitin","volume":"33","author":"Couto","year":"2022","journal-title":"Biotechnol. Rep,"},{"key":"10.1016\/j.ejpb.2025.114813_b0165","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.oftal.2016.03.001","article-title":"Platelet rich plasma in ocular surface","volume":"91","author":"Riestra","year":"2016","journal-title":"Arch. Soc. Espanola Oftalmol."},{"key":"10.1016\/j.ejpb.2025.114813_b0170","first-page":"164","article-title":"Quality standards, safety and efficacy of blood-derived serum eye drops: a review","volume":"54","author":"Van der Meer","year":"2016","journal-title":"Transfus. Apher. Sci. off. J. World Apher. Assoc. off. J. Eur. Soc. Haemapheresis"},{"key":"10.1016\/j.ejpb.2025.114813_b0175","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/jat\/bkab036","article-title":"Squaring things up with R2: what it is and what it can (and cannot) tell you","volume":"46","author":"Camirand Lemyre","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.ejpb.2025.114813_b0180","article-title":"A primer on partial least squares structural equation modeling (PLS-SEM)","author":"Hair","year":"2021","journal-title":"SAGE Publications"},{"issue":"99","key":"10.1016\/j.ejpb.2025.114813_b0185","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archopht.1981.03930010303017","article-title":"Normal human tear pH by direct measurement","volume":"1960","author":"Abelson","year":"1981","journal-title":"Arch. Ophthalmol. Chic. Ill"},{"key":"10.1016\/j.ejpb.2025.114813_b0190","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2147\/OPTH.S95242","article-title":"Tear film osmolarity and dry eye disease: a review of the literature","volume":"9","author":"Potvin","year":"2015","journal-title":"Clin. Ophthalmol. Auckl. NZ"},{"key":"10.1016\/j.ejpb.2025.114813_b0195","unstructured":"ISO 15189:2022 Medical laboratories - Requirements for quality and competence, (2022)."},{"key":"10.1016\/j.ejpb.2025.114813_b0200","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1076\/ceyr.17.10.1005.5239","article-title":"Fluorophotometric measurement of the buffering action of human tears in vivo","volume":"17","author":"Yamada","year":"1998","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejpb.2025.114813_b0205","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/j.jcrs.0000000000000508","article-title":"Role of rheology in tears and artificial tears","volume":"47","author":"Arshinoff","year":"2021","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ejpb.2025.114813_b0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11095-023-03633-7","article-title":"Comparative study of sorption phenomena between three medications and syringes made of cyclic olefin copolymer or polypropylene","volume":"41","author":"Claves","year":"2024","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114813_b0215","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3390\/mi11111007","article-title":"DoE analysis of approaches for hydrogel microbeads\u2019 preparation by millifluidic methods","volume":"11","author":"Nastruzzi","year":"2020","journal-title":"Micromachines"},{"key":"10.1016\/j.ejpb.2025.114813_b0220","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/plants12020248","article-title":"Chemical profile and biological effects of an herbal mixture for the development of an oil-in-water cream","volume":"12","author":"Safta","year":"2023","journal-title":"Plants"},{"key":"10.1016\/j.ejpb.2025.114813_b0225","doi-asserted-by":"crossref","unstructured":"C. Bogdan, Iurian ,Sonia, Tomuta ,Ioan, M. and Moldovan, Improvement of skin condition in striae distensae: development, characterization and clinical efficacy of a cosmetic product containing Punica granatum seed oil and Croton lechleri resin extract, Drug Des. Devel. Ther. 11 (2017) 521\u2013531, doi: 10.2147\/DDDT.S128470.","DOI":"10.2147\/DDDT.S128470"},{"key":"10.1016\/j.ejpb.2025.114813_b0230","doi-asserted-by":"crossref","first-page":"9609","DOI":"10.3390\/app11209609","article-title":"Development of a mouthwash using freeze-drying technique: an optimization study","volume":"11","author":"Iurian","year":"2021","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ejpb.2025.114813_b0235","first-page":"484","article-title":"QbD approach in cosmetic cleansers research: the development of a moisturizing cleansing foam focusing on thickener","volume":"10","author":"Bogdan","year":"2024","journal-title":"Surfactants, and Polyols Content, Gels"},{"key":"10.1016\/j.ejpb.2025.114813_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodhyd.2022.108416","article-title":"Current insights into protein solubility: a review of its importance for alternative proteins","volume":"137","author":"Grossmann","year":"2023","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.ejpb.2025.114813_b0245","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/1750-3841.15544","article-title":"Sensitivity of oat protein solubility to changing ionic strength and pH","volume":"86","author":"Li","year":"2021","journal-title":"J. Food Sci."},{"key":"10.1016\/j.ejpb.2025.114813_b0250","doi-asserted-by":"crossref","unstructured":"J. Cohen, Statistical Power Analysis for the Behavioral Sciences, Rev. ed., Lawrence Erlbaum Associates, Oxford, 1988. doi: 10.4324\/9780203771587.","DOI":"10.4324\/9780203771587"},{"key":"10.1016\/j.ejpb.2025.114813_b0255","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00417-022-05880-7","article-title":"The effect of sodium hyaluronate on tear film stability in patients with dry eye syndrome after cataract surgery, Graefes Arch","volume":"261","author":"Chen","year":"2023","journal-title":"Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejpb.2025.114813_b0260","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/11206721221096321","article-title":"Sodium hyaluronate 0.30% ocular gel versus sodium hyaluronate 0.18% eye drop in the treatment of moderate to severe dry eye disease","volume":"33","author":"Calonge","year":"2023","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2025.114813_b0265","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/aos.15675","article-title":"A comparison between hyaluronic acid and other single ingredient eye drops for dry eye, a review","volume":"102","author":"Hynnekleiv","year":"2024","journal-title":"Acta Ophthalmol. (Copenh.)"},{"key":"10.1016\/j.ejpb.2025.114813_b0270","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/ICL.0000000000001161","article-title":"Evaluating the protective effects of a dispersive ophthalmic viscosurgical device versus balanced salt solution on the cornea during cataract surgery","volume":"51","author":"Hanson","year":"2025","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ejpb.2025.114813_b0275","doi-asserted-by":"crossref","first-page":"e663","DOI":"10.1111\/aos.16609","article-title":"Application frequency - key indicator for the efficiency of severe dry eye disease treatment - evidence for the importance of molecular weight of hyaluronan in lubricating agents","volume":"102","author":"Medic","year":"2024","journal-title":"Acta Ophthalmol. (Copenh.)"},{"key":"10.1016\/j.ejpb.2025.114813_b0280","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10719-016-9744-5","article-title":"RGTA\u00ae or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients","volume":"34","author":"Barritault","year":"2017","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.ejpb.2025.114813_b0285","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/DHPS.S311817","article-title":"Ophthalmic solution safety profile: active surveillance of a sodium hyaluronate\/chondroitin sulfate combination in peruvian population","volume":"13","author":"Contreras-Salinas","year":"2021","journal-title":"Drug Healthc. Patient Saf."},{"key":"10.1016\/j.ejpb.2025.114813_b0290","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.3390\/jcm12237301","article-title":"Trehalose and dry eye disease: a comprehensive systematic review of randomized controlled trials","volume":"12","author":"Ballesteros-S\u00e1nchez","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejpb.2025.114813_b0295","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1007\/s40123-024-01023-9","article-title":"Overview of 37 tear substitutes in Europe based on various physicochemical parameters","volume":"13","author":"Paschier","year":"2024","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.ejpb.2025.114813_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2018.00033","article-title":"Reflections on dry eye syndrome treatment: therapeutic role of blood products","volume":"5","author":"Drew","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.ejpb.2025.114813_b0305","doi-asserted-by":"crossref","unstructured":"G. Giannaccare, P. Versura, M. Buzzi, L. Primavera, M. Pellegrini, E.C. Campos, Blood derived eye drops for the treatment of cornea and ocular surface diseases, Transfus. Apher. Sci. Off. J. World Apher. Assoc. Off. J. Eur. Soc. Haemapheresis 56 (2017) 595\u2013604. doi: 10.1016\/j.transci.2017.07.023.","DOI":"10.1016\/j.transci.2017.07.023"},{"key":"10.1016\/j.ejpb.2025.114813_b0310","doi-asserted-by":"crossref","first-page":"8906","DOI":"10.1038\/s41598-022-12879-x","article-title":"Comparison of epitheliotrophic factors in platelet-rich plasma versus autologous serum and their treatment efficacy in dry eye disease","volume":"12","author":"Metheetrairut","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2025.114813_b0315","doi-asserted-by":"crossref","first-page":"45","DOI":"10.14712\/fb2022068020045","article-title":"Time and temperature stability of TGF-\u03b21, EGF and IGF-1 in 20% and 100% human serum","volume":"68","author":"Jirsova","year":"2022","journal-title":"Folia Biol. (Praha)"},{"key":"10.1016\/j.ejpb.2025.114813_b0320","first-page":"336","article-title":"Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops","volume":"26","author":"Sahyoun","year":"2022","journal-title":"Int. J. Pharm. Compd."},{"key":"10.1016\/j.ejpb.2025.114813_b0325","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/01.ico.0000138837.52694.37","article-title":"Surface pressure measurements of human tears and individual tear film components indicate that proteins are major contributors to the surface pressure","volume":"24","author":"Tragoulias","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2025.114813_b0330","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.clae.2012.12.005","article-title":"Comparison of IgA, TNF-\u03b1 and surface tension of the tear film in two different times of the day","volume":"36","author":"Puinhas","year":"2013","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.ejpb.2025.114813_b0335","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.3390\/ijms10093793","article-title":"Trehalose metabolism: from osmoprotection to signaling","volume":"10","author":"Iturriaga","year":"2009","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2025.114813_b0340","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0009-8981(71)90203-8","article-title":"Tr\u00e9halase du s\u00e9rum humain dans quelques affections h\u00e9patiques","volume":"35","author":"Demelier","year":"1971","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejpb.2025.114813_b0345","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0009-8981(70)90174-9","article-title":"Plasma trehalase activity in diabetes mellitus","volume":"28","author":"Eze","year":"1970","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejpb.2025.114813_b0350","doi-asserted-by":"crossref","unstructured":"P. Fogagnolo, S. De Cilla\u2019, M. Alkabes, P. Sabella, L. Rossetti, A review of topical and systemic vitamin supplementation in ocular surface diseases, Nutrients 13 (2021) 1998. doi: 10.3390\/nu13061998.","DOI":"10.3390\/nu13061998"},{"key":"10.1016\/j.ejpb.2025.114813_b0355","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1542-0124(12)70185-4","article-title":"Antioxidant defenses in the ocular surface","volume":"7","author":"Chen","year":"2009","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejpb.2025.114813_b0360","doi-asserted-by":"crossref","first-page":"32688","DOI":"10.1038\/srep32688","article-title":"Lysyl oxidase-like 4 involvement in retinoic acid epithelial wound healing","volume":"6","author":"Comptour","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2025.114813_b0365","first-page":"1641","article-title":"Molecular and metabolic retinoid pathways in the human ocular surface","volume":"13","author":"Nezzar","year":"2007","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ejpb.2025.114813_b0370","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/s-0037-1606181","article-title":"The tissue factor pathway and wound healing","volume":"44","author":"Hoffman","year":"2018","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ejpb.2025.114813_b0375","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.thromres.2019.05.001","article-title":"Contribution of platelets, the coagulation and fibrinolytic systems to cutaneous wound healing","volume":"179","author":"Opneja","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejpb.2025.114813_b0380","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MBC.0000000000001268","article-title":"Commercial human frozen plasmas for local, cross-site and long-term comparability of coagulation analysers","volume":"35","author":"Launois","year":"2024","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.ejpb.2025.114813_b0385","article-title":"Stability of clotting factors in fresh frozen plasma in Yaound\u00e9","volume":"23","author":"Annick","year":"2022","journal-title":"Health Sci. Dis."},{"key":"10.1016\/j.ejpb.2025.114813_b0390","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1021\/acsbiomaterials.2c01225","article-title":"Trehalose in biomedical cryopreservation\u2013properties, mechanisms, delivery methods, applications, benefits, and problems","volume":"9","author":"Hu","year":"2023","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.ejpb.2025.114813_b0395","doi-asserted-by":"crossref","unstructured":"K. Khoshkalam, Z. Izadi, S. Sadat Mirhaji, M. Soleimanpour, M. Darabi Ghasemi, E. Barzegari, M. Jaymand, A. Lotfabadi, H. Derakhshankhah, A. Akbar Saboury, T. Ranjan Rautray, Investigation of the affinity and interaction of fibrinogen with trehalose as a protein stabilizer, J. Mol. Liq. 402 (2024) 124713. doi: 10.1016\/j.molliq.2024.124713.","DOI":"10.1016\/j.molliq.2024.124713"},{"key":"10.1016\/j.ejpb.2025.114813_b0400","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.xphs.2016.03.019","article-title":"An overview of pharmaceutical excipients: safe or not safe?","volume":"105","author":"Abrantes","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114813_b0405","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1111\/trf.17139","article-title":"Frozen and freeze-dried solvent\/detergent treated plasma: two different pharmaceutical formulations with comparable quality","volume":"62","author":"Heger","year":"2022","journal-title":"Transfusion (Paris)"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125001900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125001900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T15:17:29Z","timestamp":1753975049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125001900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":81,"alternative-id":["S0939641125001900"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114813","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an ophthalmic solution combining allogenic plasma with protective excipients for enhanced therapeutic role in the management of ocular surface diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114813","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114813"}}